Title: Insights into myalgic encephalomyelitis/chronic fatigue syndrome phenotypes through comprehensive metabolomics.
Journal: Scientific reports 20180101
14919-35-8
14919-38-1
1492-26-8
102636-82-8
6920-35-0
119793-66-7
149490-60-8 | L-N-Butylsulfonyl-p-hydroxyphenylalanine | AA001LOQ | MFCD07782139
14984-68-0 | Cloperastine hydrochloride | AA001LZB | MFCD00079012
1501153-45-2 | 1-Methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-pyrrolo[2,3-c]pyridine | AA001M9K | MFCD16996010
150433-19-5 | 3-(1-Naphthyl)-1h-pyrazole | AA001MJI | MFCD01569443
150780-67-9 | 5'-O-(4,4-Dimethoxytrityl)-2'-o-methyl-n-isobutyrylguanosine-3'-(2-cyanoethyl-n,n-diisopropyl)phosphoramidite | AA001MS7 | MFCD00792625
15129-36-9 | 1,6-Hexanediamine, N1-[(triethoxysilyl)methyl]- | AA001N5Y | MFCD01723446
15499-27-1 | 4-n-Butylchlorobenzene | AA001NG8 | MFCD00051926
155377-05-2 | Methyl 6-(trifluoromethyl)picolinate | AA001NSF | MFCD02090527
155742-64-6 | N-Methylcarbonyl-2-chloroacetamidrazone | AA001O3K | MFCD09840880
1561178-17-3 | 7H-Pyrrolo[2,3-d]pyrimidin-4-amine, 5-bromo-7-[5-deoxy-5-[[3-[[[[4-(1,1-dimethylethyl)phenyl]amino]carbonyl]amino]propyl](1-methylethyl)amino]-β-D-ribofuranosyl]- | AA001OG0 | MFCD26523136